PRKG2 and systemic sclerosis: Secondly, while we examined the effects of PRKG2 on lung cancer cells and the expression of PRKG2 in fibroblasts from lung tissues of SSc-ILD patients, we did not evaluate the effects of PRKG2 in SSc animal models, an aspect we plan to address in future research.